NO912713L - Effektive vaksiner mot bordetella pertussis omfattende enkombinasjon av individuelt rensete pertussis-antigener. - Google Patents

Effektive vaksiner mot bordetella pertussis omfattende enkombinasjon av individuelt rensete pertussis-antigener.

Info

Publication number
NO912713L
NO912713L NO91912713A NO912713A NO912713L NO 912713 L NO912713 L NO 912713L NO 91912713 A NO91912713 A NO 91912713A NO 912713 A NO912713 A NO 912713A NO 912713 L NO912713 L NO 912713L
Authority
NO
Norway
Prior art keywords
pertussis
vaccines against
effective vaccines
against table
individually cleaned
Prior art date
Application number
NO91912713A
Other languages
English (en)
Other versions
NO912713D0 (no
Inventor
Thomas G Eckhardt
John W Gotto
David K Mcclintock
Jane V Scott
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24192174&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO912713(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of NO912713D0 publication Critical patent/NO912713D0/no
Publication of NO912713L publication Critical patent/NO912713L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO91912713A 1990-07-11 1991-07-10 Effektive vaksiner mot bordetella pertussis omfattende enkombinasjon av individuelt rensete pertussis-antigener. NO912713L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US54923690A 1990-07-11 1990-07-11

Publications (2)

Publication Number Publication Date
NO912713D0 NO912713D0 (no) 1991-07-10
NO912713L true NO912713L (no) 1992-01-13

Family

ID=24192174

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91912713A NO912713L (no) 1990-07-11 1991-07-10 Effektive vaksiner mot bordetella pertussis omfattende enkombinasjon av individuelt rensete pertussis-antigener.

Country Status (10)

Country Link
US (4) US5885587A (no)
EP (1) EP0484621A3 (no)
JP (1) JPH04230328A (no)
KR (1) KR920002790A (no)
AU (1) AU8033591A (no)
CA (1) CA2046543A1 (no)
FI (1) FI913350A (no)
IL (1) IL98233A0 (no)
NO (1) NO912713L (no)
PT (1) PT98257A (no)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8412207D0 (en) 1984-05-12 1984-06-20 Wellcome Found Antigenic preparations
GB8910570D0 (en) 1989-05-08 1989-06-21 Wellcome Found Acellular vaccine
US5156958A (en) * 1990-09-21 1992-10-20 American Cyanamid Company Gene encoding a 30 kilodalton outer membrane protein of bordetella pertussis and method of recombinant production of said protein
US6444211B2 (en) * 1991-04-03 2002-09-03 Connaught Laboratories, Inc. Purification of a pertussis outer membrane protein
GB9209118D0 (en) * 1992-04-28 1992-06-10 Sb 120 Amsterdam Bv Vaccine compositions
DK0725653T3 (da) 1993-10-05 2004-10-11 Celltech Pharmaceuticals Ltd Vaccinepræparater
DE69511392T2 (de) * 1994-04-28 2000-03-23 Takeda Chemical Industries, Ltd. Verfahren zur trennung von protektiven verbindungen aus bordetella pertussis
EP1234580A1 (en) * 1995-05-04 2002-08-28 Aventis Pasteur Limited Acellular Pertussis Vaccines and Methods of Preparation Thereof
US20030157129A1 (en) * 1995-06-23 2003-08-21 Smithkline Beecham Biologicals S.A. Vaccine comprising a polysaccharide antigen - carrier protein conjugate and free carrier protein
US20020054884A1 (en) 1995-06-23 2002-05-09 Smithkline Beecham Biologicals, Sa Vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate
GB9611501D0 (en) * 1996-06-03 1996-08-07 Smithkline Beecham Biolog Vaccine compositions
RU2194531C2 (ru) * 1996-07-02 2002-12-20 Коннот Лабораториз Лимитед Поливалентные ассоциированные коклюшно-дифтерийно-столбнячно (акдс)-полиомиелитные вакцины
US20010014331A1 (en) * 1996-11-07 2001-08-16 Smithkline Beecham Biologicals S.A. Acellular pertussis vaccine with diphthriae-and tetanus-toxoids
US7087236B1 (en) 1998-09-01 2006-08-08 Merrion Research I Limited Method for inducing a cell-mediated immune response and improved parenteral vaccine formulations thereof
US7172762B1 (en) * 1999-01-29 2007-02-06 Pfizer Inc. Erysipelothrix rhusiopathiae antigens and vaccine compositions
US20020009466A1 (en) * 1999-08-31 2002-01-24 David J. Brayden Oral vaccine compositions
JP2001085516A (ja) * 1999-09-10 2001-03-30 Oki Electric Ind Co Ltd 半導体装置の製造方法
GB9924351D0 (en) 1999-10-14 1999-12-15 Brennan Frank Immunomodulation methods and compositions
FR2809960B1 (fr) * 2000-06-07 2004-04-23 Pasteur Institut Composition adjuvante de la reponse immunitaire comprenant la proteine fha ou un fragment de la proteine fha sous forme libre, et composition immunogene ou vaccinale contenant une telle composition adjuvante
US20020051794A1 (en) * 2000-08-09 2002-05-02 Alk-Abello A/S Novel parenteral vaccine formulations and uses thereof
KR100401423B1 (ko) * 2001-01-10 2003-10-17 주식회사 엘지생명과학 혼합 백신의 제조 방법
WO2003086204A2 (en) * 2002-04-09 2003-10-23 Neville Alleyne Bone fixation apparatus
WO2005032584A2 (en) 2003-10-02 2005-04-14 Glaxosmithkline Biologicals S.A. Pertussis antigens and use thereof in vaccination
US7578803B2 (en) * 2004-03-18 2009-08-25 C. R. Bard, Inc. Multifunction adaptor for an open-ended catheter
US20060115499A1 (en) * 2004-09-27 2006-06-01 Alk-Abello A/S Liquid allergy vaccine formulation for oromucosal administration
EP1828378B1 (en) * 2004-12-17 2014-06-11 De Staat der Nederlanden, vert. door de minister Van VWS, Ministerie van Volksgezondheid, Welzijn en Sport Deacylation of lps in gram negative bacteria
JP5207380B2 (ja) * 2006-03-27 2013-06-12 北里第一三共ワクチン株式会社 長期保存においても毒性復帰がおこらない特徴を持つ全菌体細菌ワクチンならびにその用途
MX2009002560A (es) 2006-09-07 2009-03-20 Glaxosmithkline Biolog Sa Vacuna.
EP2139993A2 (en) * 2007-04-27 2010-01-06 Dow Global Technologies Inc. Improved production and in vivo assembly of soluble recombinant icosahedral virus-like particles
KR100906369B1 (ko) 2009-01-14 2009-07-06 김세영 수유 쿠션
US8916173B2 (en) 2013-03-08 2014-12-23 Crucell Holland B.V. Acellular pertussis vaccine
CA3022602A1 (en) 2016-05-10 2017-11-16 Najit Technologies, Inc. Inorganic polyatomic oxyanions for protecting against antigenic damage during pathogen inactivation for vaccine production
WO2023043988A1 (en) * 2021-09-17 2023-03-23 Advanced Rx Compositions, methods, systems and kits for the treatment of nosebleeds

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3043291A1 (de) * 1980-11-17 1982-07-01 Dso Pharmachim Vakzine gegen keuchhusten
CA1209036A (en) * 1982-08-20 1986-08-05 Joseph S.C. Kuo Combined haemophilus influenzae and diphtheria, pertussis, tetanus vaccine
GB8412207D0 (en) * 1984-05-12 1984-06-20 Wellcome Found Antigenic preparations
FR2590483B1 (fr) * 1985-11-22 1988-12-09 Pasteur Institut Antigenes purifies ayant des proprietes vaccinantes contre b. pertussis, moyens notamment adns recombinants pour les produire et compositions de vaccins les contenant
GB8601279D0 (en) * 1986-01-20 1986-02-26 Public Health Lab Service Purification of pertussis antigens
FR2597344B1 (fr) * 1986-04-16 1989-06-23 Merieux Inst Perfectionnement au procede de purification d'antigenes proteiques de bacteries appartenant au genre bordetella, en vue de l'obtention d'un vaccin acellulaire.
GB8910570D0 (en) * 1989-05-08 1989-06-21 Wellcome Found Acellular vaccine
US5276142A (en) * 1989-12-11 1994-01-04 American Cyanamid Company Process for purification of a 69000 dalton antigenic protein from Bordetella pertussis
US5578308A (en) * 1990-02-12 1996-11-26 Capiau; Carine Glutaraldehyde and formalin detoxified bordetella toxin vaccine
IT1248735B (it) * 1990-06-21 1995-01-26 Sclavo Spa Vaccini acellulari contro la pertosse

Also Published As

Publication number Publication date
AU8033591A (en) 1992-01-16
US5885586A (en) 1999-03-23
EP0484621A3 (en) 1992-08-26
PT98257A (pt) 1992-04-30
FI913350A0 (fi) 1991-07-10
NO912713D0 (no) 1991-07-10
JPH04230328A (ja) 1992-08-19
IL98233A0 (en) 1992-06-21
US5895655A (en) 1999-04-20
US5885587A (en) 1999-03-23
CA2046543A1 (en) 1992-01-12
KR920002790A (ko) 1992-02-28
US5897867A (en) 1999-04-27
FI913350A (fi) 1992-01-12
EP0484621A2 (en) 1992-05-13

Similar Documents

Publication Publication Date Title
NO912713L (no) Effektive vaksiner mot bordetella pertussis omfattende enkombinasjon av individuelt rensete pertussis-antigener.
DK0512017T3 (da) Vacciner
FI954514A (fi) 3-O-deasyloitua monofosforyylilipidiä A sisältävä rokotekoostumus
ATE188613T1 (de) Adjuvantien enthaltende impfstoffzusammensetzung
DK0633784T3 (da) Hepatitisvacciner indeholdende 3-O-diacyleret monophosphoryl-lipid A
NL300189I1 (nl) Acellulair vaccin.
IT1248735B (it) Vaccini acellulari contro la pertosse
EP0474646A4 (en) Bordetella vaccines
NL990018I1 (nl) Vaccin tegen Pasteurella.
DK355789D0 (da) Bordetella pertussis vaccine
ATA903091A (de) Holzbeheizter steinofen holzbeheizter steinofen
EP0563323A4 (en) Hiv reverse transcriptase vaccine
KR890701743A (ko) B형 간염 표면 항원 백신
GB9021004D0 (en) Acellular vaccines
KR910014925U (ko) 말벌 포살용기
IT9021453A1 (it) Manufatto imbottito per arredamento
MX9100808A (es) Antigenos superficiales inmunodominantes de la entomoeba histolitica.
KR920005885U (ko) 불교용 목탁
KR910013907U (ko) 지압등받이 겸용 베개
GB9006097D0 (en) Vaccines
GB9011358D0 (en) Vaccines
KR920011200U (ko) 진공청소기
IL95006A0 (en) Oral vaccines
ITNA920012V0 (it) Incastro di sostegno per appoggio per compenenti di arredo urbano in marmo (o altri materiali9.
IT9064227U1 (it) Levigatrice per pavimenti